# Chapter 107: Inhalant Use Disorder

# Chapter X: The Biological and Neurological Basis of Inhalant Use Disorder

## Introduction

Inhalant Use Disorder (IUD), often referred to as solvent abuse or volatile substance abuse, represents a unique and particularly pernicious category within the broader spectrum of substance-related and addictive disorders (Straussner et al., 2012). The disorder is characterized by the deliberate inhalation of volatile chemical vapors from a wide array of common household and industrial products for the purpose of achieving a psychoactive, or mind-altering, effect (Corrigan, 1994; Gorny, 1994; Rastegar, 2020). These substances, which include organic solvents, aerosols, gases, and nitrites, are pharmacologically diverse but share a common route of administration that allows for rapid absorption into the bloodstream and subsequent entry into the central nervous system (CNS) (Rastegar, 2025; Miller & Gold, 1990). The resulting intoxication often resembles that produced by alcohol, characterized by initial excitation, euphoria, disinhibition, wooziness, and drowsiness (Vyas et al., 2012; Corrigan, 1994).

From a public health perspective, IUD is a rising concern, particularly among children and adolescents, for whom inhalants are often the first mood-altering drugs used due to their low cost, legal status, and easy availability (Vyas et al., 2012; Espeland, 1995; Simlai & Khess, 2008; Wang & Hoyte, 2018). This pattern of early initiation places a vulnerable, developing population at significant risk (Gorny, 1994; Oetting et al., 1989). While often overlooked in public discourse in favor of more well-known drugs like cocaine or heroin, the abuse of inhalants can lead to devastating health consequences, including severe and often irreversible damage to vital organs such as the brain, heart, kidneys, and liver (Vyas et al., 2012; Espeland, 1995). Even a single episode of inhalant abuse can result in serious health problems, and in severe cases, can be fatal due to mechanisms such as "sudden sniffing death syndrome," suffocation, seizures, or coma (Simlai & Khess, 2008; Vyas et al., 2012; Petekkaya et al., 2016).

The persistence of inhalant abuse, despite its profound risks, points toward a powerful addictive process underpinned by distinct biological and neurological mechanisms (Jayaswal & Singh, 2025). Addiction, in its broadest sense, is a condition where an individual feels a strong, compulsive need to take a drug, often losing control over its use despite harmful consequences (Kenadi, 2021; Rebec, 2005; DuPont, 1998). Inhalant abuse fits this profile, with users often engaging in repeated abuse to prolong the period of intoxication (Vyas et al., 2012). This compulsive pattern suggests that, like other drugs of abuse, inhalants hijack the brain's natural reward and control systems, leading to a state of dependence (Vicente et al., 2012).

This chapter aims to provide a comprehensive overview of the biological and neurological basis of Inhalant Use Disorder. It will synthesize the existing evidence on the neuropharmacological actions of various inhaled substances, their impact on specific brain regions and neural circuits, and the resulting structural and functional neuropathology. Drawing upon direct research into volatile substances and making cautious parallels with more extensively studied drugs of abuse like alcohol, cocaine, and nicotine, this chapter will explore the cellular, genetic, and developmental factors that contribute to the initiation, maintenance, and consequences of IUD. By elucidating the complex interplay between these volatile chemicals and the brain, we can better understand the devastating trajectory of this disorder and inform the development of more effective prevention and treatment strategies.

## Neurobiological Systems

The neurobiological impact of inhalant abuse is multifaceted, stemming from both the direct pharmacological actions of the inhaled chemicals and the profound physiological insults, such as hypoxia, that accompany their use (Rastegar, 2020). The diverse nature of these substances—ranging from volatile solvents like toluene to gases like butane and nitrous oxide—means that their effects are not mediated by a single mechanism but rather through a constellation of interactions with the central nervous system (CNS) (Rastegar, 2025; Miller & Gold, 1990). These interactions disrupt normal neurotransmission, alter neural circuits, and can lead to significant and often permanent neuropathology.

### Neurotransmitter Systems and Neuropharmacology

The acute psychoactive effects of inhalants provide clues to their underlying neuropharmacology. Users report an initial stimulation and euphoria, followed by CNS depression, disinhibition, drowsiness, and sometimes hallucinations (Vyas et al., 2012; Praveen et al., 2009; Unknown, 2002). This biphasic effect profile suggests interactions with multiple neurotransmitter systems.

The most frequently noted comparison is to alcohol intoxication (Corrigan, 1994; Boztaş & Arısoy, 2010). This clinical similarity strongly suggests that, like ethanol, many volatile solvents act on the GABAergic and glutamatergic systems (Peoples, 2002). Specifically, they are thought to enhance the function of GABA-A receptors, the primary inhibitory neurotransmitter system in the brain, leading to the observed depressant effects such as drowsiness, disinhibition, and impaired motor coordination (Boztaş & Arısoy, 2010; Peoples, 2002). Concurrently, they may inhibit the function of NMDA glutamate receptors, a key excitatory system, further contributing to CNS depression and cognitive impairment (Peoples, 2002). This dual action on inhibitory and excitatory systems is a hallmark of many CNS depressants, including alcohol and barbiturates (Gerada & Ashworth, 1997).

The euphoric and reinforcing properties of inhalants point to a crucial role for the mesolimbic dopamine system, the brain's primary reward pathway (Vicente et al., 2012). This system is a common target for virtually all drugs of abuse, including cocaine, amphetamines, and nicotine, which increase dopamine release in structures like the nucleus accumbens, creating the pleasurable sensations that drive continued use (Gawin, 1991; Hope, 1999; Henningfield et al., 1995). The desire to prolong the intoxicated state and the development of compulsive use patterns in inhalant abusers are consistent with the hijacking of this reward circuitry (Vyas et al., 2012; Vanderschuren & Everitt, 2004). The addictive potential of these substances is therefore rooted in these powerful reinforcing effects on the brain's dopamine system (Goldstein, 2001).

Furthermore, some inhalants may interact with other neurotransmitter systems. For example, the hallucinogenic properties reported by some users suggest possible modulation of the serotonin system, similar to drugs like LSD (Imperi, 1968; Woody, 1970). The observation that antidepressants can be effective in treating individuals with comorbid IUD and depression hints at a potential dysregulation of serotonergic or noradrenergic pathways in these individuals (Vaibhavi & Shivakumar, 2024). The diversity of the chemicals involved means that specific substances may have unique pharmacological profiles; for instance, amyl nitrite and related compounds are potent vasodilators, and their abuse is associated with profound hypotension, an effect mediated through different pathways than the CNS depression of volatile solvents (Rastegar, 2020). Similarly, anesthetic gases like nitrous oxide have complex mechanisms that include NMDA receptor antagonism (Rastegar, 2025).

### Brain Regions, Neural Circuits, and Functional Connectivity

Chronic inhalant abuse is associated with severe and widespread structural damage to the brain, directly impacting neural circuits and their functional connectivity. Neuroimaging studies in chronic users have revealed profound morphological abnormalities (Tania et al., 2016). These include diffuse brain atrophy, particularly affecting the cerebrum, cerebellum, and brain stem, which is visible as ventricular dilation and widening of the cortical sulci (Boztaş & Arısoy, 2010). This widespread tissue loss is a clear indication of extensive neuronal death and degeneration.

The specific regions affected correspond to the clinical symptoms observed in chronic users. Cerebellar atrophy, for instance, directly correlates with the motor coordination deficits, ataxia (difficulty walking), and tremors seen in these individuals (Tenenbein, 1997; Boztaş & Arısoy, 2010). The cerebellum is critical for fine-tuning motor activity, and its degradation leads to these characteristic neurological signs. Damage to corticospinal tracts, also reported, further contributes to motor system impairment (Tenenbein, 1997).

The development of severe cognitive deficits, including dementia and persistent psychosis, points to significant damage in cortical regions, especially the prefrontal cortex, and limbic structures like the hippocampus (Tenenbein, 1997; O'Flynn, 1988). The prefrontal cortex is the seat of executive functions—such as judgment, impulse control, and decision-making—and its impairment is a central feature of addiction pathology across substances (Goldstein, 2008). The profound impairment of judgment noted in inhalant users (Press & Done, 1967) is a direct functional consequence of damage to this region. The disruption of functional connectivity between the prefrontal cortex and subcortical reward structures likely underlies the loss of control over substance use that defines addiction (Goldstein, 2008; Vanderschuren & Everitt, 2004).

Another critical mechanism of brain damage is hypoxia or anoxia (Rastegar, 2020). Many inhalants, such as butane and propane, are asphyxiant gases that displace oxygen in the lungs, leading to a state of severe oxygen deprivation in the brain (Petekkaya et al., 2016; Avis & Archibald, 1994). This can cause acute hypoxic-ischemic brain injury, a condition that can result in widespread neuronal death, coma, seizures, and severe, permanent neurological sequelae (Kaya et al., 2020; Ceylan et al., 2020). Even a single, high-concentration exposure can be sufficient to cause irreversible brain damage through this mechanism (Simlai & Khess, 2008). Therefore, the neurobiological consequences of IUD arise from a dual assault on the brain: the direct neurotoxicity of the chemicals and the devastating effects of oxygen deprivation.

## Genetic and Molecular Basis

The development of Inhalant Use Disorder, like other addictions, is not solely a matter of exposure; it arises from a complex interplay of environmental, psychological, and biological factors (Oetting et al., 1988). While direct genetic studies on IUD are scarce in the provided literature, principles derived from research on other substance use disorders, such as those related to alcohol and nicotine, suggest that genetic predispositions likely play a significant role in determining an individual's vulnerability (Benowitz, 1992; Bendre, 2019). Addiction is understood to be a heritable condition, where genetic factors can influence everything from initial sensitivity to a drug's effects to the metabolism of the substance and the propensity to develop compulsive use patterns (Goldstein, 2001; Kandyala et al., 2011). The observation that inhalant abuse is often a risk factor for subsequent misuse of other substances, such as heroin or cocaine, further supports the idea of a shared underlying vulnerability that may have a genetic component (Özkan & Oto, 2001; Davies et al., 1985).

At the molecular level, the damage caused by inhalants is profound and occurs through several distinct mechanisms. First and foremost is direct cellular toxicity. Most volatile organic solvents are highly lipophilic, meaning they readily dissolve in fats (Press & Done, 1967). Since the brain is a lipid-rich organ and neuronal membranes are composed of lipid bilayers, these solvents can easily penetrate the CNS and disrupt cellular function (Boztaş & Arısoy, 2010). They can alter membrane fluidity, interfere with the function of embedded proteins such as receptors and ion channels, and ultimately lead to cell death (Unknown, 2002). This direct neurotoxic action is a primary driver of the diffuse brain atrophy observed in chronic users (Boztaş & Arısoy, 2010).

Specific components of certain inhalants are known to be potent neurotoxins. For example, leaded gasoline contains tetraethyl lead, an organometallic compound with well-documented, severe neurotoxic effects that contribute to the development of a persistent and severe encephalopathy (Tenenbein, 1997). Similarly, other solvents like toluene have been implicated in causing specific patterns of brain damage (Gürses et al., 2014; Miller & Gold, 1990). The molecular basis of this toxicity involves interference with cellular metabolism, generation of oxidative stress, and induction of inflammatory pathways that culminate in neuronal injury and apoptosis (Tania et al., 2016).

A second critical molecular mechanism is hypoxia, or oxygen deprivation (Rastegar, 2020). Asphyxiant gases like butane and propane, commonly found in lighter refills and aerosols, do not have a primary pharmacological effect but cause harm by displacing oxygen from inhaled air (Petekkaya et al., 2016; Avis & Archibald, 1994). When a user inhales these substances, particularly in an enclosed space or using a plastic bag, the concentration of oxygen in the lungs and subsequently in the blood plummets (Murty, 2008). Brain tissue is exceptionally sensitive to hypoxia; within minutes of oxygen deprivation, irreversible neuronal damage begins to occur (Kaya et al., 2020). This can lead to acute consequences such as seizures, coma, and sudden death (Ceylan et al., 2020; Vyas et al., 2012). The molecular cascade triggered by hypoxia involves a failure of aerobic metabolism, a breakdown of ion gradients, excitotoxicity, and ultimately, cell death, contributing significantly to the global brain damage seen in IUD (Kaya et al., 2020).

A third mechanism involves the formation of toxic metabolites. The body attempts to break down and eliminate foreign chemicals, but sometimes this metabolic process can create compounds that are even more toxic than the parent substance (Camacho, 2009). The specific metabolic pathways for many volatile solvents are complex, but it is known that they can generate reactive intermediates that damage cellular components, including DNA, proteins, and lipids, further contributing to organ damage in the brain, liver, and kidneys (Vyas et al., 2012). For example, methanol, found in some industrial solvents, is metabolized to formic acid, which is highly toxic and causes specific damage to the optic nerve and basal ganglia (Gussow, 2016). The combination of direct toxicity, hypoxia, and the generation of harmful metabolites creates a powerful molecular assault that underlies the severe pathophysiology of IUD.

## Brain Structure and Function

The chronic abuse of inhalants inflicts devastating and often permanent damage on the structure and function of the brain (Vyas et al., 2012). This damage is not localized but diffuse, reflecting the global distribution of these lipid-soluble chemicals and the brain's universal dependence on oxygen (Press & Done, 1967). The resulting neuropathology is evident in both macroscopic structural changes detectable via neuroimaging and the profound functional impairments observed clinically.

### Neuroimaging Findings

Modern neuroimaging techniques have provided a window into the structural consequences of long-term inhalant abuse, revealing a consistent pattern of widespread neurodegeneration. One of the most striking findings is diffuse cerebral atrophy, characterized by a generalized loss of brain tissue volume (Boztaş & Arısoy, 2010). This shrinkage of the brain is often accompanied by a corresponding enlargement of the ventricular system (ventricular dilation) and a widening of the sulci, the grooves on the surface of the brain (Boztaş & Arısoy, 2010). These morphological abnormalities are direct evidence of substantial neuronal and glial cell loss across the cerebrum (Tania et al., 2016).

In addition to the cerebrum, the cerebellum and brain stem are also frequently and severely affected (Boztaş & Arısoy, 2010). Cerebellar atrophy is particularly common and is the anatomical correlate of the ataxia, dysarthria, and intention tremors that are characteristic neurological signs of chronic solvent abuse (Tenenbein, 1997). The cerebellum's critical role in motor control and coordination means that its degeneration leads directly to these debilitating movement disorders.

The white matter of the brain, which consists of myelinated nerve fibers that connect different brain regions, is also highly vulnerable. The lipophilic nature of solvents allows them to damage the myelin sheath, a fatty substance that insulates nerve fibers and is essential for rapid neural communication. This demyelination disrupts the structural and functional integrity of the brain's communication networks. This pathology contributes to a condition known as toxic encephalopathy, a diffuse brain dysfunction characterized by a range of cognitive, motor, and psychiatric symptoms (Rastegar, 2020; Tenenbein, 1997).

In cases of acute intoxication, particularly those involving asphyxiant gases, neuroimaging can reveal evidence of hypoxic-ischemic injury (Kaya et al., 2020). This type of injury results from a lack of oxygen and blood flow to the brain and typically affects areas with high metabolic demand, such as the basal ganglia, hippocampus, and cerebral cortex. The resulting damage can be catastrophic, leading to severe and permanent neurological and mental sequelae (Kaya et al., 2020).

### Functional Impairments and Connectivity

The structural damage documented by neuroimaging has direct and severe functional consequences. Chronic inhalant abusers exhibit a wide spectrum of cognitive impairments that often progress to a state of dementia (Tenenbein, 1997; O'Flynn, 1988). These deficits include problems with memory, attention, concentration, and executive functions such as planning, problem-solving, and impulse control (Press & Done, 1967). The impairment of executive functions, which are largely governed by the prefrontal cortex, is particularly significant, as it contributes to the poor judgment and loss of control over drug use that are central to addiction (Goldstein, 2008).

The widespread brain atrophy and white matter damage disrupt the functional connectivity between brain regions. While not directly studied in the provided literature, it can be inferred that the efficient communication required for complex cognitive tasks is compromised. The circuits connecting the prefrontal cortex with limbic areas (involved in emotion and reward) and motor regions are likely to be particularly affected, leading to a disconnection between judgment, emotional regulation, and behavior. This breakdown in neural communication can explain the combination of cognitive decline, emotional lability, and impulsive actions seen in individuals with IUD (Oetting et al., 1988).

Psychiatric symptoms are also common functional consequences. Users may experience persistent psychosis, anxiety, and depression (Tenenbein, 1997; Vaibhavi & Shivakumar, 2024). These conditions may arise from direct toxic effects on the neural circuits that regulate mood and perception, or they may reflect the brain's response to chronic injury. The high comorbidity between IUD and other mental health disorders suggests a shared or interacting neurobiological substrate (Özkan & Oto, 2001). For instance, the emotional problems, anger, and alienation noted in young inhalant users may be both a risk factor for and a consequence of the drug's effects on limbic and prefrontal circuits (Oetting et al., 1988). Ultimately, the combination of direct neurotoxicity and recurrent hypoxic insults leads to a global decline in brain function, leaving many chronic users with profound and irreversible neurological and psychiatric disability (Miller & Gold, 1990).

## Developmental Neurobiology

Inhalant Use Disorder is disproportionately a phenomenon of the young (Gorny, 1994; Simlai & Khess, 2008). The highest prevalence of use is found among adolescents, with initiation often occurring in the preadolescent or early teenage years (Rastegar, 2020; Wang & Hoyte, 2018; Oetting et al., 1989). This epidemiological pattern is of profound neurobiological concern, as exposure to potent neurotoxins and asphyxiants during the critical period of adolescent brain development can have uniquely severe and long-lasting consequences (George & Vaccarino, 2015).

### The Vulnerable Adolescent Brain

Adolescence is a period of dynamic and extensive brain maturation, characterized by processes such as synaptic pruning, myelination, and significant remodeling of key neural circuits, particularly within the prefrontal cortex and limbic system (Grant & Bélanger, 2017). These regions are responsible for higher-order cognitive functions, including decision-making, impulse control, emotional regulation, and risk assessment—faculties that are not fully mature until the mid-twenties (Towner & Varlinskaya, 2020). The developing brain is uniquely vulnerable to the disruptive effects of psychoactive substances (George & Vaccarino, 2015). Exposure to drugs like alcohol, cannabis, and nicotine during this sensitive window can alter the trajectory of brain development, leading to lasting deficits in brain structure and function (Knopf, 2016; Grant & Bélanger, 2017; Henningfield & Jude, 1999).

Inhalants represent a particularly grave threat to the adolescent brain for several reasons. First, the volatile solvents and gases directly attack the neural infrastructure. Their lipophilic nature allows them to readily damage cell membranes and the myelin sheath (Press & Done, 1967). Myelination is a key developmental process in adolescence that increases the speed and efficiency of neural communication; disruption of this process by solvents can lead to permanent deficits in cognitive processing and motor skills (Boztaş & Arısoy, 2010). Second, the hypoxic and anoxic events associated with inhalant abuse can cause widespread neuronal death, which is especially devastating in a brain that is still organizing and strengthening its neural networks (Kaya et al., 2020; Rastegar, 2025). The damage inflicted during this period may not be recoverable and can set the stage for lifelong cognitive and psychiatric problems (Stone, 2015).

### Inhalants as a Gateway Substance

Clinically and epidemiologically, inhalants often serve as one of the first substances of abuse for children and young adolescents, preceding the use of alcohol, tobacco, or marijuana (Espeland, 1995; Gorny, 1994). This early initiation is a significant risk factor for the development of a broader pattern of substance misuse (Özkan & Oto, 2001). Studies have documented a progression from early solvent sniffing to later abuse of more "traditional" illicit drugs like heroin (Davies et al., 1985). This "gateway" effect may have a neurobiological basis (Williams, 2020). Early and repeated exposure to the intense, rapid psychoactive effects of inhalants may prime the adolescent brain's reward system, making it more sensitive to the reinforcing properties of other drugs (Vicente et al., 2012). This sensitization can lower the threshold for developing addiction to other substances later in life.

Furthermore, the social and psychological factors underlying early inhalant abuse, such as emotional distress, anger, and alienation, are also risk factors for other forms of substance use and risky behaviors (Oetting et al., 1988). Young inhalant users often come from broken homes or poor backgrounds and associate with peer clusters who are also involved in drug use (Simlai & Khess, 2008; Oetting et al., 1988). The combination of a vulnerable, developing brain and a high-risk psychosocial environment creates a powerful trajectory toward chronic polysubstance use and its associated negative consequences (Miller & Gold, 1990). The early onset of inhalant abuse, therefore, is not just a risk for immediate toxicity but a critical marker for a developmental pathway that can lead to a lifetime of addiction and related health problems (Jayaswal & Singh, 2025).

## Treatment Mechanisms

Despite the severity of Inhalant Use Disorder and its devastating neurological consequences, the development of specific, evidence-based biological treatments has lagged significantly behind that of other substance use disorders (Rastegar, 2020). The available literature points to a general lack of data on effective treatment modalities, highlighting a critical area for future research (Rastegar, 2025). Current management primarily focuses on detoxification, supportive care, and addressing comorbid psychiatric conditions, with the biological basis of these interventions drawn from principles of general toxicology and addiction medicine.

### Management of Acute Intoxication and Withdrawal

The immediate biological goal in treating acute inhalant intoxication is stabilization and prevention of further harm (Camacho, 2009). Since many acute deaths are caused by cardiac arrhythmias ("sudden sniffing death syndrome") or respiratory depression and asphyxia, initial management focuses on ensuring airway patency, providing supplemental oxygen, and monitoring cardiovascular function (Simlai & Khess, 2008; Espeland, 1995). The use of oxygen therapy is a critical intervention to counteract the profound hypoxia that can occur with the inhalation of asphyxiant gases like butane or propane (Rastegar, 2020; Petekkaya et al., 2016). This directly addresses a primary mechanism of brain and organ injury (Kaya et al., 2020).

Following cessation of use, individuals may experience a withdrawal syndrome, although its characteristics are less defined than for substances like alcohol or opioids (Vyas et al., 2012). A significant risk during this period is the occurrence of seizures, which points to a state of CNS hyperexcitability following the removal of the depressant effects of the volatile substances (Vyas et al., 2012; Ceylan et al., 2020). The biological basis for treating this state involves the use of medications that stabilize neuronal activity, similar to the management of alcohol withdrawal (Stern et al., 2010). Benzodiazepines, which enhance GABAergic inhibition, are a logical choice for preventing or treating seizures and managing agitation, drawing a direct parallel to standard protocols for alcohol detoxification (Gower & Kersten, 1980; Daley & Douaihy, 2019).

### Pharmacological Approaches for Comorbidity and Relapse Prevention

There are currently no FDA-approved medications specifically for the treatment of IUD itself (Daley & Douaihy, 2019). However, pharmacotherapy often plays a crucial role in managing the high rates of comorbid psychiatric disorders seen in this population (Miller & Gold, 1990). A case report demonstrated that an adolescent with both IUD (petrol sniffing) and persistent depressive disorder showed improvement in both conditions when treated with antidepressants (Vaibhavi & Shivakumar, 2024). This suggests that targeting underlying or co-occurring neurochemical imbalances, such as those in the serotonin system, may be a viable therapeutic strategy. By alleviating depressive symptoms, these medications may reduce the "need" or motivation to use inhalants as a form of self-medication for emotional distress (Oetting et al., 1988).

Extrapolating from other addictions, a major biological target for relapse prevention is the craving for the drug's euphoric effects, which is driven by the dopamine reward system (Kosten, 1992). Medications that modulate dopamine activity could theoretically reduce the reinforcing value of inhalants and decrease craving. However, no such agents have been systematically studied for IUD. Similarly, understanding the role of other systems, such as the GABA/glutamate balance, could lead to the exploration of agents like acamprosate, which is used in alcohol use disorder to stabilize this balance and reduce protracted withdrawal symptoms (Winslow et al., 2016).

Given the current landscape, the most promising biological treatment strategies involve a multi-pronged approach: supportive care and oxygen to mitigate acute toxicity and hypoxia; benzodiazepines for management of withdrawal and seizures; and targeted pharmacotherapy, such as antidepressants, for comorbid psychiatric conditions (Vaibhavi & Shivakumar, 2024; Daley & Douaihy, 2019). The development of novel treatments will depend on a more detailed understanding of the specific neuropharmacological actions of different classes of inhalants.

## Future Directions

The study of the biological and neurological basis of Inhalant Use Disorder is fraught with challenges, yet it is an area of urgent public health importance (Vyas et al., 2012). While our current understanding has been built upon clinical observation, toxicology reports, and a limited number of neuroimaging and animal studies, significant gaps in knowledge remain (Rastegar, 2020). Future research must adopt a more systematic and mechanistic approach to unravel the complex pathophysiology of this disorder.

A primary challenge is the sheer heterogeneity of the substances abused (Rastegar, 2025). Inhalants are not a single class of drug but a collection of hundreds of different chemicals with diverse pharmacological properties (Miller & Gold, 1990). Future neuropharmacological research needs to move beyond general descriptions of "alcohol-like" effects and dissect the specific molecular targets of common solvents like toluene, gases like butane, and nitrites. Identifying their precise interactions with neurotransmitter receptors (e.g., GABA-A, NMDA, dopamine, serotonin) and ion channels is a critical step toward understanding their psychoactive and toxic effects. This will require sophisticated preclinical models, including in vitro receptor binding assays and in vivo electrophysiology.

Advanced neuroimaging represents a powerful tool for future investigations. While initial studies have documented gross morphological changes like diffuse brain atrophy (Boztaş & Arısoy, 2010; Tania et al., 2016), longitudinal studies are desperately needed. Tracking changes in brain structure and function from early use in adolescence through to adulthood would provide invaluable insight into the developmental trajectory of brain damage and could help identify critical windows of vulnerability. Functional neuroimaging techniques, such as fMRI, could be employed to examine how inhalants disrupt neural circuit function in real-time, particularly in networks related to reward, executive control, and motor coordination, building on the frameworks established in cocaine and alcohol research (Goldstein, 2008).

The field of genetics and molecular biology is another crucial frontier. Identifying specific genes that may confer vulnerability to IUD could help in targeting prevention efforts toward at-risk individuals (Benowitz, 1992). Research should explore whether genetic variations in drug-metabolizing enzymes or neurotransmitter receptor subtypes influence an individual's risk of developing dependence. Furthermore, molecular studies should investigate the precise mechanisms of neurotoxicity, focusing on pathways of oxidative stress, inflammation, mitochondrial dysfunction, and apoptosis, which may be common to many volatile solvents. The intriguing finding of glial plasticity in response to solvent exposure warrants deeper investigation, as understanding the brain's cellular response to injury could reveal novel therapeutic targets (Tania et al., 2016).

Finally, and perhaps most importantly, there is a pressing need for clinical trials to develop and test effective pharmacological treatments. Based on the presumed neurobiological mechanisms, future studies could investigate the efficacy of agents that modulate the GABA/glutamate systems, dopamine pathways, or serotonin function in reducing craving and preventing relapse in individuals with IUD. Given the high rate of comorbid psychiatric illness (Vaibhavi & Shivakumar, 2024), research should also focus on integrated treatment approaches that simultaneously address both the addiction and the underlying mental health condition. Acknowledging the current lack of specific treatments (Rastegar, 2020) and the severe consequences of IUD, a concerted, multidisciplinary research effort is essential to move the field forward and provide hope for those affected by this devastating disorder.

## Conclusion

Inhalant Use Disorder represents a complex and severe form of addiction, distinguished by the use of readily available volatile substances that inflict profound damage upon the central nervous system and other vital organs (Vyas et al., 2012; Miller & Gold, 1990). The biological and neurological underpinnings of this disorder are rooted in a dual pathology: the direct neurotoxic and psychoactive effects of a diverse array of chemicals, and the severe, often catastrophic, consequences of brain hypoxia (Rastegar, 2020; Kaya et al., 2020). The acute effects, often described as similar to alcohol intoxication, suggest a primary mechanism involving the potentiation of inhibitory GABAergic systems and inhibition of excitatory glutamatergic systems, while the reinforcing euphoria points to the hijacking of the mesolimbic dopamine pathway, a common final pathway for most drugs of abuse (Corrigan, 1994; Vicente et al., 2012).

Chronic exposure leads to devastating and frequently irreversible structural brain damage. Neuroimaging evidence consistently reveals widespread cerebral, cerebellar, and brainstem atrophy, a stark testament to the extensive neuronal loss caused by these substances (Boztaş & Arısoy, 2010; Tania et al., 2016). This diffuse pathology manifests clinically as a spectrum of debilitating neurological and psychiatric conditions, including motor deficits, cognitive impairment, dementia, and persistent psychosis (Tenenbein, 1997; O'Flynn, 1988). The particular prevalence of inhalant abuse among adolescents is of paramount concern, as exposure during this critical period of neurodevelopment can permanently alter the brain's maturational trajectory, increasing the risk for lifelong addiction and mental health problems (Gorny, 1994; George & Vaccarino, 2015).

Despite the gravity of IUD, our scientific understanding of its specific biological mechanisms remains incomplete, and the development of targeted treatments is in its infancy (Rastegar, 2025). The heterogeneity of the abused substances presents a significant challenge, necessitating a more nuanced research approach that can differentiate the effects of various chemical classes. While parallels drawn from alcohol and cocaine research provide a foundational framework, dedicated investigation into the unique neuropharmacology of inhalants is essential. Future progress will depend on leveraging advanced neuroimaging, genetic and molecular studies, and well-designed clinical trials to illuminate the precise pathways of damage and to identify effective biological interventions. Ultimately, a deeper comprehension of the neurobiology of IUD is not merely an academic exercise; it is a critical necessity for developing effective strategies to prevent and treat this destructive disorder and mitigate its tragic impact on individuals, families, and society.

## References

1. Abbass, S. K. (2008). EFFECTS OF SMOKING AND AGE ON THE VALIDITY OF PARTIAL DENTURE AFTER TWO YEARS OF USE: STATISTICAL STUDY. Journal of university of Anbar for pure science. https://doi.org/10.37652/juaps.2008.15364
2. Abiven, G. (2001). Le goût et l'odorat chez les personnes âgées. Age and Nutrition.
3. Acuff, S. F., & Strickland, J. C. (2025). Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target. Addiction. https://doi.org/10.1111/add.70048
4. Adamson, R. H. (1995). Caffeine Dependence Syndrome. JAMA. https://doi.org/10.1001/jama.1995.03520420029022
5. Ahmad, N., Bano, R. P., Agarwal, V., & Kalakoti, P. (2009). SUBSTANCE ABUSE IN INDIA. Pravara medical review.
6. Ahmed, S. H. (2010). Escalation of Drug Use. Neuromethods. https://doi.org/10.1007/978-1-60761-934-5_10
7. Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., & Hapke, E. (2019). Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduction Journal. https://doi.org/10.1186/s12954-019-0308-4
8. Avis, S. P., & Archibald, J. (1994). Asphyxial Suicide by Propane Inhalation and Plastic Bag Suffocation. Journal of Forensic Sciences. https://doi.org/10.1520/jfs13593j
9. Beltrán, K., & Cardona, W. (2018). Medical and dental effects of energy drinks consumption. Literature review.. International Journal of Medical and Surgical Sciences. https://doi.org/10.32457/ijmss.2017.013
10. Bendre, M. (2019). Predictors of Alcohol Misuse : Role of MAOA Genotype, Methylation, Transcription, and Negative and Positive Environmental factors.
11. Benowitz, N. L. (1992). The Genetics of Drug Dependence: Tobacco Addiction. New England Journal of Medicine. https://doi.org/10.1056/nejm199209173271210
12. Berezhnova, I., Antonov, N. S., Sakharova, G. M., Donitova, V. V., Kotov, A. A., & Latif, E. (2014). ELECTRONIC CIGARETTE: ASSESSMENT OF SAFETY AND RISK FOR HEALTH. PULMONOLOGIYA. https://doi.org/10.18093/0869-0189-2014-0-3-122-127
13. Blacker, C. J. (2020). Clinical Issues to Consider for Clozapine Patients Who Vape: A Case Illustration. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20190025
14. Blalock, S. J., Gregory, P. J., Patel, R. A., Norton, L., Callahan, L. F., & Jordan, J. M. (2009). Factors associated with potential medication-herb/natural product interactions in a rural community.. Alternative therapies in health and medicine.
15. Bolinder, G., & Gilljam, H. (2015). Smokeless Tobacco - Health Hazards or Less Harm?. Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research. https://doi.org/10.1159/000369503
16. Bondy, S. J., Victor, J. C., Diemert, L., Mecredy, G., Chaiton, M., Brown, K. S., Cohen, J. E., McDonald, P., Ferrence, R., Garcia, J., Selby, P., & Schwartz, R. (2012). Transitions in Smoking Status Over Time in a Population-Based Panel Study of Smokers. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/nts259
17. Borrello, S. J. (2010). Help your patients with smoking cessation. Nursing Made Incredibly Easy!. https://doi.org/10.1097/01.nme.0000368753.31333.08
18. Boström, G. (2001). Chapter 6. Habits of Life and Public Health. Scandinavian Journal of Public Health. https://doi.org/10.1177/14034948010290032301
19. Bradberry, S., & Vale, A. (2010). Lead poisoning: The use of dimercaptosuccinic acid (DMSA). The Biochemist. https://doi.org/10.1042/bio03204014
20. Bsc, R. G., & Benton, D. (1994). Impact of Vitamin/Mineral Supplementation on the Attention and Intelligence Scores of an 8-Year-Old Boy. Journal of Nutritional Medicine. https://doi.org/10.3109/13590849409034542
21. Budson, A. E., & O’Connor, M. K. (2021). How to manage problems with bodily functions. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0011
22. Buettner‐Schmidt, K., Swanson, K. M., Maack, B., Barnacle, M., Miller, D. R., Orr, M., & Gag, M. H. (2021). E-cigarettes for tobacco cessation. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000798228.69915.64
23. Burger, M., Ms, B., & Jm, V. D. K. (2011). [Suicide attempt with antidepressants ordered from the Internet].. PubMed.
24. Burghardt, K. J., & Ellingrod, V. L. (2012). Smoking Cessation: What to Tell Patients about Over-the-Counter Treatments. Current psychiatry.
25. Buus, D., Alzoubaidi, M., & Jamous, F. (2019). Vaping Induced Lung Injury: A Case Report.. PubMed.
26. Byrne, J. J., & Saade, G. R. (2020). Smoking, Vaping, and Nicotine Exposure. https://doi.org/10.1002/9781119635307.ch2
27. Cabello-Vázquez, M., & Yagüe-Olmos, C. (2008). Programa de deshabituación tabáquica para internos y trabajadores de un centro penitenciario. Revista Española de Sanidad Penitenciaria. https://doi.org/10.4321/s1575-06202008000200005
28. Calero, J. D. R., Rey, E. J. A. D., & Rey, M. (1998). El consumo de drogas por adolescentes y jóvenes. Tarbiya: Revista de investigación e innovación educativa.
29. Camacho, M. (2009). Ingested poisons in adults. Nursing Made Incredibly Easy!. https://doi.org/10.1097/01.nme.0000350935.04413.f8
30. Cari, A. G., Brambila, M. Á. L., Solís, R. E. C., & Mendoza-Meléndez, M. Á. (2014). Inhalables y otras aspiraciones. Ciencia - Academia Mexicana de Ciencias.
31. Carnahan, R. M., Kutscher, E. C., Obritsch, M. D., & Rasmussen, L. D. (2005). Acute Ethanol Intoxication After Consumption of Hairspray. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.2005.25.11.1646
32. Cattacin, S. (2012). Spielräume und Regulierungen in einer berauschenden Gesellschaft. Seismo eBooks.
33. Ceylan, N., Özdemir, F. M. A., Çelık, H. İ., Azapağası, E., Yazıcı, M. U., & Yüksel, D. (2020). A rare case of intoxication related to concurrent exposure to butane gas and energy drink. Journal of Substance Use. https://doi.org/10.1080/14659891.2020.1821804
34. Chaiken, J. M., & Chaiken, M. R. (1990). Drugs and Predatory Crime. Crime and Justice. https://doi.org/10.1086/449176
35. Chaitanya, B. K., & Madhuri, I. (2021). EFFECT OF ORAL TOBACCO ON VITAL DATA. Indian Journal Of Applied Research. https://doi.org/10.36106/ijar/4101865
36. Chamberlain, C., & Coleman, T. (2020). Tobacco Smoking in Pregnancy. Cambridge University Press eBooks. https://doi.org/10.1017/9781108163705.019
37. Choi, N. G., & DiNitto, D. M. (2014). Role of New Diagnosis, Social Isolation, and Depression in Older Adults’ Smoking Cessation. The Gerontologist. https://doi.org/10.1093/geront/gnu049
38. Chuah, L. O., Yeap, S. K., Ho, W. Y., Beh, B. K., & Alitheen, N. B. (2012). <i>In Vitro</i>and<i>In Vivo</i>Toxicity of<i>Garcinia</i>or Hydroxycitric Acid: A Review. Evidence-based Complementary and Alternative Medicine. https://doi.org/10.1155/2012/197920
39. Cobb, C. O., Hendricks, P. S., & Eissenberg, T. (2015). Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Medicine. https://doi.org/10.1186/s12916-015-0355-y
40. Coelho, D. P., Marongio, I. S., Nascimento, M. E. M. F., Barboza, V. A. N., Félix, L. F., Marques, L. V. D. S., & Garcia, S. C. M. (2024). O uso de cigarros eletrônicos atrelado a infecções pulmonares em jovens. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.1576.10.2024
41. Compton, M. T., & Broussard, B. (2010). Staying Healthy. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0020
42. Cooter, G. R. (1980). Amphetamine Use, Physical Activity and Sport. Journal of Drug Issues. https://doi.org/10.1177/002204268001000303
43. Corrigan, D. (1994). Solvent abuse: a guide for professionals and parents..
44. Cortes, I. C. C., Coelho, J. F. A. B., Vaz, M. D. S., Mendes, E. M., & Rocha, A. M. (2019). Alterações bucais em pacientes fumantes. Revista de Odontologia Contemporânea. https://doi.org/10.31991/iiisdpbucalv3n1201917
45. Costa, J. L. D., Aguiar, D. M. D., & Souto, Á. D. O. (2019). As consequências sociais, familiares, físicas e psíquicas do dependente de álcool.
46. Curicho-Casco, J. V., Acosta-Salas, E. N., García-Villacrés, J. A., & Benites, R. M. (2024). El alcohol y los tejidos bucodentales. Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida. https://doi.org/10.35381/s.v.v8i1.3890
47. Dadi, S. (2015). Smoking and its Effects on Men?s Sexual Health. Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences.
48. Daha, M. K. (2021). pengaruh merokok bagi remaja dan pergaulan sehari hari. https://doi.org/10.31219/osf.io/gvtfa
49. Daha, M. K. (2021). Pengaruh merokok bagi remaja dan pergaulan sehari hari. https://doi.org/10.31219/osf.io/y39fd
50. Dahlgren, A., Lidal, I. B., Mosdøl, A., Odgaard‐Jensen, J., Denison, E., & Vist, G. E. (2015). Effects of Information and Other Communication Initiatives on Physical Activity with One or More Other Lifestyle Habits Targeting the General Population [Internet].
51. Daley, D. C., & Douaihy, A. (2019). Alcohol and Drug Problems. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0001
52. Daley, D. C., & Douaihy, A. (2019). Medications for Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926670.003.0015
53. Daley, D. C., & Douaihy, A. (2019). Relapse After a Period of Recovery. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0007
54. Davies, B., Thorley, A., & O’Connor, D. W. (1985). Progression of addiction careers in young adult solvent misusers.. BMJ. https://doi.org/10.1136/bmj.290.6462.109
55. Deehan, G. A., Waeiss, R. A., Hauser, S. R., Engleman, E. A., McBride, W. J., & Rodd, Z. A. (2015). SY18EVERYTHING MIXES WITH ALCOHOL: RECENT ADVANCES IN THE STUDY OF ALCOHOL POLYDRUG USESY18-1THE CO-ABUSE OF ALCOHOL AND NICOTINE: EXAMINING THE UNDERLYING BEHAVIORAL AND NEUROBIOLOGICAL MECHANISMS. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agv076.74
56. Deepmala, D., Bali, S., Taneja, M., & Choudhary, P. (2019). Effects of drug abuse on oral health. Santosh University Journal of Health Sciences. https://doi.org/10.18231/2455-1732.2018.0016
57. Delás, J., Blanqué, J. M., & González, V. B. (2010). El cannabis y sus peligros. El Ciervo: revista mensual de pensamiento y cultura.
58. DeSimone, A., Murray, P. I., & Lester, D. (1994). Alcohol use, self-esteem, depression, and suicidality in high school students.. PubMed.
59. Dilber, D., Barić, H., Novinščak, T., & Čerkez-Habek, J. (2016). Herbal incense-related sudden death: case report. Journal of Substance Use. https://doi.org/10.3109/14659891.2016.1162212
60. Dino, G., Pignataro, R. M., Breland, A., Murray, P. J., & Horn, K. (2011). Adolescent smoking cessation: promising strategies and evidence-based recommendations.. PubMed.
61. Dooy, J. D., Hal, G. V., Laecke, G. V., & Ramet, J. (2012). 39 Binge Drinking: Not an Innocent Problem. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2012-302724.0039
62. Douglass, R. S., & Heckman, G. (2010). Drug-related taste disturbance: a contributing factor in geriatric syndromes.. PubMed.
63. Driscoll, D. (2019). Drug Addiction and Substance Abuse in Rural New Hampshire. OALib. https://doi.org/10.4236/oalib.1105093
64. DuPont, R. L. (1998). Addiction: a new paradigm.. PubMed.
65. Echeverrı́a, V. (2012). Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2012.00173
66. Eckerson, J. M. (2008). Weight Loss Nutritional Supplements. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-231-1_8
67. Edwards, M. (2008). Lead poisoning: a public health issue. Primary Health Care. https://doi.org/10.7748/phc.18.3.18.s23
68. Edwards, R. W., Oetting, E. R., & Beauvais, F. (1989). Drugs and Native-American Youth. Drugs & Society. https://doi.org/10.1300/j023v03n01_01
69. Edwards, R., Oetting, E. R., & Beauvais, F. (1988). Social and Psychological Factors Underlying Inhalant Abuse. PsycEXTRA Dataset. https://doi.org/10.1037/e496592006-010
70. Ekblom‐Bak, E., Ekblom, B., & Hellénius, M.-L. (2010). Minskat stillasittande lika viktigt som ökad fysisk aktivitet : [Less sitting as important as increased physical activity]. Läkartidningen/Läkartidningen.
71. Enser, B., & Foxcroft, D. (2019). The Harms and Prevention of Drugs and Alcohol on Children. https://doi.org/10.1093/obo/9780199791231-0216
72. Ericsdotter, F. A., & Safi, S. N. (2015). Äta för att leva.
73. Espeland, K. (1995). Identifying the Manifestations of Inhalant Abuse. The Nurse Practitioner. https://doi.org/10.1097/00006205-199505000-00010
74. Exner, J., Seifritz, E., & Malte, C. (2020). Use of psychotropic substances in elite sports. Swiss Sports & Exercise Medicine. https://doi.org/10.34045/sems/2020/34
75. Farzaei, M. H., Bayrami, Z., Farzaei, F., Aneva, I., Das, S. K., Patra, J. K., Das, G., & Abdollahi, M. (2020). Poisoning by Medical Plants..
76. Feldkircher, K. C. G. (2014). INTOXICAÇÃO MEDICAMENTOSA EM ANIMAIS DOMÉSTICOS.
77. Fernández, M. D. F., & Ubago, J. G. (2008). Síndrome de dependencia del alcohol. Jano: Medicina y humanidades.
78. Ferreira, J. C. M., & Alves, J. C. B. (2009). ALCOOLISMO: DA DEPENDÊNCIA AOS BENEFÍCIOS DA ATIVIDADE FÍSICA. Fiep Bulletin - online.
79. Finnerty, F., Fitzpatrick, C., Stockwell, S., & Richardson, D. (2019). The changing face of male sexual assault: recreational drug use and multiple assailants. Sexually Transmitted Infections. https://doi.org/10.1136/sextrans-2019-054174
80. Fleisher, D., Sweet, B. V., & Parekh, A. (2004). Drug Absorption With Food. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-781-9_7
81. Fletcher, G. O., Dawes, J., & Spano, M. (2014). The Potential Dangers of Using Rapid Weight Loss Techniques. Strength and conditioning journal. https://doi.org/10.1519/ssc.0000000000000043
82. Floyd, L. K. (2020). Ask, Advise, Assist, and Follow: Alcohol SBiRT Urgently Needed. The Journal for Nurse Practitioners. https://doi.org/10.1016/j.nurpra.2020.10.035
83. Frank, S., & Burkhalter, T. (2020). Dehydration and Cognition. Journal of Food & Nutritional Disorders.
84. Frazee, S. G., Muzina, D. J., & Nease, R. F. (2014). Strategies to Overcome Medication Nonadherence. JAMA. https://doi.org/10.1001/jama.2014.1760
85. Frye, C. C. J., Rung, J. M., Nall, R. W., Galizio, A., Haynes, J. M., & Odum, A. L. (2018). Continuous nicotine exposure does not affect resurgence of alcohol seeking in rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0202230
86. Galaj, E., Barrera, E. D., Morris, D., Ma, Y., & Ranaldi, R. (2020). Aberrations in Incentive Learning and Responding to Heroin in Male Rats After Adolescent or Adult Chronic Binge‐Like Alcohol Exposure. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.14341
87. Gawin, F. H. (1991). Cocaine Addiction: Psychology and Neurophysiology. Science. https://doi.org/10.1126/science.2011738
88. George, T. P., & Vaccarino, F. J. (2015). The effects of cannabis use during adolescence..
89. Gerada, C., & Ashworth, M. (1997). ABC of mental health: Addiction and dependence II: Alcohol. BMJ. https://doi.org/10.1136/bmj.315.7104.358
90. Gerada, C., & Ashworth, M. T. (1997). ABC of mental health: Addiction and dependence I: Illicit drugs. BMJ. https://doi.org/10.1136/bmj.315.7103.297
91. Gi, S., & Av, F. (2010). [Modern aspects of war against smoking: are there any opportunities left?].. Kardiologiia.
92. Gil, F. G., Andrade, A. G. D., & Castaldelli-Maia, J. M. (2016). Discussing prevalence, impacts, and treatment of substance use disorders in athletes. International Review of Psychiatry. https://doi.org/10.1080/09540261.2016.1212821
93. Goldberg, M. E. (2008). Why New Tobacco “Harm-Reduction” Products should be Regulated. Journal of Public Policy & Marketing. https://doi.org/10.1509/jppm.27.2.182
94. Goldstein, A. (2001). Are Addicts Born or Made?. Addiction. https://doi.org/10.1093/oso/9780195146639.003.0007
95. Goldstein, R. Z. (2008). Self-Control in Cocaine Addiction (440th Brookhaven Lecture).
96. Gordon, A., Moran, D. T., Jafek, B. W., Eller, P. M., & Strahan, R. C. (1990). The Effect of Chronic Cocaine Abuse on Human Olfaction. Archives of Otolaryngology - Head and Neck Surgery. https://doi.org/10.1001/archotol.1990.01870120061010
97. Gorny, S. W. (1994). Inhalant Abuse as an Adolescent Drug Problem: An.
98. Goyal, A., Sriganesh, K., Pallavi, K., & Krishnakumar, M. (2020). Flavoured hookah and perioperative risk: Evil goes global. Indian Journal of Anaesthesia. https://doi.org/10.4103/ija.ija_54_20
99. Gracie, K., & Hancox, R. J. (2020). Cannabis use disorder and the lungs. Addiction. https://doi.org/10.1111/add.15075
100. Grant, C. N., & Bélanger, R. E. (2017). Cannabis and Canada’s children and youth. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx017
101. Grief, S. N., & Miranda, R. L. (2010). Weight loss maintenance.. PubMed.
102. Gupta, C., & Prakash, D. (2020). Nutraceutical Intervention for Treatment of Alcoholism and Drinking Problems. Apple Academic Press eBooks. https://doi.org/10.1201/9780367821517-15
103. Gussow, L. (2016). Toxicology Rounds. Emergency Medicine News. https://doi.org/10.1097/01.eem.0000482468.05462.85
104. Göller, T. (2016). Askese in der Konsumgesellschaft.
105. Gürses, M. S., Türkmen, N., Eren, B., Çeti̇n, S., & Gündoğmuş, Ü. N. (2014). Death due to combined intake of ethanol and toluene: a case report.. PubMed.
106. Hadis, M. A., Palin, W. M., Perryer, D. G., & Burke, F. T. (2017). Advice for festive drinkers. Dental Update. https://doi.org/10.12968/denu.2017.44.11.1076
107. Hall, J. W., Espir, M. L., Shirreffs, J. G., & Stevens, D. L. (1970). For Debate: Impotence in Farm Workers using Toxic Chemicals. BMJ. https://doi.org/10.1136/bmj.1.5693.423
108. Hamidli, S., Yetkin, A., Yalccedil, & Yetkin, N. (2010). The meaning of life: Health, disease, and the naturopathy. International Journal of Psychology and Behavioral Sciences. https://doi.org/10.5897/ijpc.9000054
109. Hartmann‐Boyce, J., & Aveyard, P. (2016). Drugs for smoking cessation. BMJ. https://doi.org/10.1136/bmj.i571
110. Hedaoo, S. A., & Mahapatra, D. K. (2020). Exploring the Hidden Ethnobotanical Treasures for Treating or Managing Chronic Alcoholism. Apple Academic Press eBooks. https://doi.org/10.1201/9781003057932-2
111. Henningfield, J. E., & Jude, N. O. (1999). Prevention of nicotine addiction: Neuropsychopharmacological issues. Nicotine & Tobacco Research. https://doi.org/10.1080/14622299050011581
112. Henningfield, J. E., Schuh, L. M., & Heishman, S. J. (1995). Pharmacological Determinants of Cigarette Smoking. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7445-8_32
113. Henry, S. L., Jamner, L. D., & Whalen, C. K. (2012). I (should) Need a Cigarette: Adolescent Social Anxiety and Cigarette Smoking. Annals of Behavioral Medicine. https://doi.org/10.1007/s12160-011-9340-7
114. Hesami, Z., Alvanpour, A., Sharif-Kashani, B., Tafti, S. F., & Heydari, G. (2010). Severity of Nicotine Withdrawal Symptoms after Smoking Cessation.
115. Hodge, J. G., & Scanlon, M. (2014). The Legal Anatomy of Product Bans to Protect the Public's Health. SSRN Electronic Journal.
116. Hong, B. (2019). Can smokers be helped to reduce the harm caused by cigarette smoking by smoking fewer cigarettes or using different tobacco products?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.2648
117. Hope, B. T. (1999). Cocaine and a Mechanism for Long-Term Changes in Gene Expression. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-710-9_21
118. Ibrahim, D. H. M. O. (2019). A Novel Treatment for Constipation by Sesame Seeds. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2019.1070
119. Ide, S., & Ikeda, K. (2020). Animal models in addiction research. Proceedings for Annual Meeting of The Japanese Pharmacological Society. https://doi.org/10.1254/jpssuppl.93.0_1-s04-2
120. Imperi, L. L. (1968). Use of Hallucinogenic Drugs on Campus. JAMA. https://doi.org/10.1001/jama.1968.03140250001001
121. Imperi, L. L. (1968). Use of hallucinogenic drugs on campus. JAMA. https://doi.org/10.1001/jama.204.12.1021
122. Imperi, L. L., Kleber, H. D., & Davie, J. S. (1968). Use of hallucinogenic drugs on campus.. PubMed.
123. Irving, P. W. (2016). LibGuides: Common Content - Alcohol & Other Drugs: Co-morbidity.
124. Irving, P. W. (2016). LibGuides: Common Content - Alcohol & Other Drugs: The Australian Context.
125. Issa, S. Y., Hafez, E. M., Al-Mazroua, M. K., Saad, M., & Arabia, S. (2015). Fatal Suicidal Ingestion of Aluminum Phosphide in an adult Syrian female- A Clinical Case study.
126. Jargin, S. V. (2015). Hormesis. Human & Experimental Toxicology. https://doi.org/10.1177/0960327114564796
127. Jargin, S. V. (2015). Some Aspects of Nonbeverage Alcohol Consumption in the Former Soviet Union. Psychiatry Journal. https://doi.org/10.1155/2015/507391
128. Jayaswal, A., & Singh, D. P. (2025). Substance Abuse and Its Addiction Among Young Adults. INTERNATIONAL JOURNAL OF PROFESSIONAL STUDIES. https://doi.org/10.37648/ijps.v20i01.012
129. Jerez, A. F. H., Gil, F., & Martínez, A. P. (1999). Nuevas perspectivas en el análisis de drogas de abuso para el año 2000. Revista electrónica de ciencia penal y criminología.
130. Johnson, E. M., & Belfer, M. L. (1995). Substance Abuse and Violence: Cause and Consequence. Journal of Health Care for the Poor and Underserved. https://doi.org/10.1353/hpu.2010.0578
131. Jorge-Cárdenas, X. D. S., Beverido-Sustaeta, P., & Salas-García, B. (2015). Significados y valores del uso, abuso y adicción a la mariguana. Revista Electrónica Medicina, Salud y Sociedad. https://doi.org/10.25009/remsys.2015.2.147
132. Jose, J. V., Arya, J. S., & Thykkattil, S. J. (2024). Understanding the Concept of Madya and Madatyaya with Respect to Alcohol Use Disorders. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i03.23214
133. Joule, R. V., Fointiat, V., Pasquier, C., & Mugny, G. (1991). Behavioural conversion in a compliance paradigm: A replication and a refinement. European Journal of Social Psychology. https://doi.org/10.1002/ejsp.2420210409
134. Joyce, K. M., Thompson, K., Tibbo, P., Good, K. P., O'Leary, E., Perrot, T. S., Hudson, A. L., & Stewart, S. H. (2021). The Impact of Depressed Mood and Coping Motives in those with Pre-Menstrual Dysphoric Disorder on Cannabis Use Quantity across the Menstrual Cycle. https://doi.org/10.26828/cannabis.2021.01.000.40
135. Kalra, S., Bhogal, S., Kumar, K., Ragupathi, N. K. D., & Kaushal, R. K. (2021). The Negative Impact of Food Neophobia on the People of Chandigarh Tri-City, India. SPAST Abstracts.
136. Kamrul, R., Bunka, D., CRAWLEY, A. E., Schuster, B., & LeBras, M. (2019). Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.. PubMed.
137. Kandyala, R., Nalabolu, G. R., Pinisetty, S., & Rajashekaran, S. T. (2011). Tobacco Addiction - Blame it on Genes!. International journal of oral and maxillofacial pathology.
138. Kane, G. C. (2009). Drug Interactions with Food and Beverages. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-431-9_35
139. Kaplan, C. D., HUSCH, J. A., & BIELEMAN, B. (1994). The prevention of stimulant misuse. Addiction. https://doi.org/10.1111/j.1360-0443.1994.tb03752.x
140. Kaskie, B., Martinos, F., Bhagianadh, D., Arora, K., Moore, A., Nguyen, A. L., & Bobitt, J. (2025). Taking Care of Themselves: Cannabis Use Among Informal Care Partners of Older Adults. Cannabis and Cannabinoid Research. https://doi.org/10.1177/25785125251380073
141. Kattekola, P. K. (2020). Alochol Addiction and its Treatment. Journal of Drug Abuse.
142. Kaur, J., Rossi, A., Adams, S. K., Varowal, M. S., Jain, L., Raza, M., & Sarfraz, Z. (2025). Novel Treatments for Adolescent Vaping Cessation: Are We There Yet?. Journal of Community Hospital Internal Medicine Perspectives. https://doi.org/10.55729/2000-9666.1526
143. Kaya, A., Temürkol, S. C., Özçalışkan, B., & Güler, H. (2020). Adli Bir Olgu Olarak Çakmak Gazı İnhalasyonu ve Nörolojik Sekelleri. Deleted Journal. https://doi.org/10.17986/blm.1327
144. Kenadi, S. (2021). A NOTE on DRUG and ADDICTION EFFECTS. Journal of Alcoholism and Drug Dependence.
145. Kendall, M. D. (1998). Patterns of Life. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511525346.004
146. Kengadaran, S., Anusha, D., Caplan, D. J., Sivasamy, S., & Divyaraj, P. (2025). Smokeless Tobacco Products in India – A Scoping Review. SBV Journal of Basic Clinical and Applied Health Science. https://doi.org/10.4103/sbvj.sbvj_29_25
147. Khodaee, A., Reed, A. J., & Khodaee, M. (2025). Electronic Cigarette Use (Vaping) Among Adolescents: A Narrative Review of an Emerging Public Health Epidemic. Cureus. https://doi.org/10.7759/cureus.89422
148. Kim, S., Lee, Y.-M., Lee, K., Park, J.-S., Park, J.-H., Choi, B. H., & Park, S. (2016). An Unexpected Death Related to Accidental Gasoline Inhalation. Korean Journal of Legal Medicine. https://doi.org/10.7580/kjlm.2016.40.3.83
149. Kitzen, J. M., McConaha, J. L., Bookser, M. L., Pergolizzi, J. V., Taylor, R., & Raffa, R. B. (2019). e‐Cigarettes for smoking cessation: Do they deliver?. Journal of Clinical Pharmacy and Therapeutics. https://doi.org/10.1111/jcpt.12833
150. Knopf, A. (2016). Nonwhite youth have more academic problems on alcohol and marijuana than white youth. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30145
151. Kondratavičiūtė, G., Banionis, D., Laima, S., Chmieliauskas, S., Vasiljevaitė, D., Petreikis, P., & Badaras, R. (2025). Sudden Unexpected Death and Alcohol Addiction: Case Report on Disulfiram Use. Acta medica Lituanica. https://doi.org/10.15388/amed.2025.32.1.5
152. Koplan, K., David, S. P., & Rigotti, N. A. (2008). Smoking cessation. BMJ. https://doi.org/10.1136/bmj.39248.531748.47
153. Kornetsky, C., Moolten, M. S., & Bain, G. T. (1991). Ethanol and Rewarding Brain Stimulation. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4757-1305-3_9
154. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.1992.tb00029.x
155. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?: Drug Craving and Relapse in Opioid and Cocaine Dependence. American Journal on Addictions. https://doi.org/10.3109/10550499209004025
156. Kozer, E., & Koren, G. (2001). Effects of prenatal exposure to marijuana.. PubMed.
157. Krzesinski, J.-M., & Ancion, G. (2001). [Sports and hypertension].. PubMed.
158. Kumar, J., Kushwaha, S., Tomar, A., Ramanna, T., Prabhakar, I., & Chaudhry, M. (2015). Tobacco and Oral Health . The Journal of Dentists. https://doi.org/10.12974/2311-8695.2015.03.01.2
159. Lamis, D. A., Ellis, J. B., Chumney, F. L., & Dula, C. S. (2009). Reasons for Living and Alcohol Use Among College Students. Death Studies. https://doi.org/10.1080/07481180802672017
160. Lampkin, C. (2020). Healthy Living During Extraordinary Times: Exercise and Stress. https://doi.org/10.26419/res.00386.003
161. Laplace, A. C., Chermack, S. T., & Taylor, S. P. (1994). Effects of Alcohol and Drinking Experience on Human Physical Aggression. Personality and Social Psychology Bulletin. https://doi.org/10.1177/0146167294204011
162. Laupu, W. (2018). Recommendations to Help Prevent Mental Disorders and Limit Stigma. British Journal of Medical and Health Research. https://doi.org/10.46624/bjmhr.2018.v5.i09.001
163. Lee, C., Vo, T. T. T., Wee, Y., Chiang, Y., Chi, M., Chen, M., Hsu, L., Fang, M.-L., Lee, K., Guo, S., Cheng, J. H.-C., & Lee, I. (2021). The Adverse Impact of Incense Smoke on Human Health: From Mechanisms to Implications. Journal of Inflammation Research. https://doi.org/10.2147/jir.s332771
164. London, M., O'REGAN, T., Aust, P., & STOCKFORD, A. (1990). Poppy tea drinking in East Anglia. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1990.tb01611.x
165. Lopes, P. M. A., Dias, A. P. S., Zanini, É. R. S., Camboin, F. F., Seimetz, G., & Ferreira, L. (2012). Smoking Sue e os Efeitos do Tabagismo. 10º Congresso Internacional da Rede Unida.
166. Lucas, G., Neeper, M., Linde, B. D., & Bennett, J. (2017). Preventing Prescription Drug Misuse in Work Settings: Efficacy of a Brief Intervention in Health Consciousness. Journal of Medical Internet Research. https://doi.org/10.2196/jmir.7828
167. Ludwig, D. S. (2012). Weight Loss Strategies for Adolescents. JAMA. https://doi.org/10.1001/jama.2011.2011
168. Macdonald, D. I. (1985). Drug abuse in adolescents. Postgraduate Medicine. https://doi.org/10.1080/00325481.1985.11699144
169. Malacari, S. S. (2010). NUEVAS FORMAS DE CONSUMO. II Congreso Internacional de Investigación y Práctica Profesional en Psicología XVII Jornadas de Investigación Sexto Encuentro de Investigadores en Psicología del MERCOSUR.
170. Marques, P. S., & Oliveira, M. S. D. (2016). SAÚDE MENTAL E INTELECTUAL NO TRABALHO. Proceedings of World Congress on Communication and Arts. https://doi.org/10.14684/wcca.v8.190-191
171. Masloman, S. K. (2020). Tinjauan Sosiologi Hukum Terhadap Penyalahgunaan Narkoba Di Kalangan Anggota Legislatif. JURNAL LEGALITAS. https://doi.org/10.33756/jelta.v13i01.7306
172. Maughan, R. J. (2005). Contamination of dietary supplements and positive drug tests in sport. Journal of Sports Sciences. https://doi.org/10.1080/02640410400023258
173. Maughan, R., Al-Kharusi, W., Binnett, M. S., Budgett, R., Burke, L. M., Coyle, E. F., Elwani, R., Guézennec, C.-Y., Limna, J., Mujika, I., Ramadan, J., Schamasch, P., Shirreffs, S. M., & Vennard, P. (2010). Fasting and sports: a summary statement of the IOC workshop. British Journal of Sports Medicine. https://doi.org/10.1136/bjsm.2010.073064
174. McBride, J. S., Altman, D. G., Klein, M.-L., & White, W. L. (1998). Green tobacco sickness. Tobacco Control. https://doi.org/10.1136/tc.7.3.294
175. McDonough, S. P., & Southard, T. (2016). Toxicology Testing. https://doi.org/10.1002/9781119317005.ch20
176. McNeill, A. D., Brose, L. S., Calder, R. I., Hitchman, S. C., Hájek, P., & McRobbie, H. (2015). E-cigarettes: an evidence update. A report commissioned by Public Health England..
177. Mendoza, C. G., Martínez, C. A. L., & Gutiérrez, A. G. T. (2020). Consumo de psicofármacos: una problemática de salud actual. DOAJ (DOAJ: Directory of Open Access Journals).
178. Menecier, P., Verny, M., Fernandez, L., & Ploton, L. (2016). Alcoholic abstinence in elderly subjects with misuse of alcohol. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2016.0600
179. Menezes, N. G. A., Silva, G. K. R. D., & Ferreira, C. S. (2014). Atuação do Enfermeiro Frente à Dependência Química da Cocaína.. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
180. Mileva, B., Dikov, T., Goshev, M., Georgieva, M., Tsranchev, I. I., Angelov, M., Alexandrov, A., Ateriya, N., & Ivanova, V. (2024). Death Following Methyl Alcohol Intoxication: Gross Autopsy and Histological Findings. Cureus. https://doi.org/10.7759/cureus.65498
181. Millatmal, T., Daughton, D. M., Thompson, A. B., Floreani, A. A., Romberger, D. J., Epperson, K., Larson, L., & Rennard, S. I. (1994). Smoking reduction: an alternative approach for smokers who cannot quit.. PubMed.
182. Miller, N. F., & Gold, M. S. (1990). Organic Solvents and Aerosols: An Overview of Abuse and Dependence. Annals of Clinical Psychiatry. https://doi.org/10.3109/10401239009149553
183. Mirambeaux-Villalona, R., Granda‐Orive, J. I. D., Arroyo-Cózar, M., Calero-Pardo, S., Vaquero-Lozano, P., Vargas-Espinal, J. C., Sánchez-Carpintero, M., & Jiménez-Ruíz, C. A. (2025). Reducción hasta dejarlo: papel de la terapia sustitutiva con nicotina. https://doi.org/10.69703/pt.v27i1.4
184. Mixich, R. (2020). Štetne navike studenata - pušenje, alkohol i prekomjerna tjelesna težina.
185. Monk, T. H., Houck, P. R., & Shear, M. K. (2005). The Daily Life of Complicated Grief Patients—What Gets Missed, What Gets Added?. Death Studies. https://doi.org/10.1080/07481180500348860
186. Montain, S. J. (2008). Hydration Recommendations for Sport 2008. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0b013e31817f005f
187. Morgan, F., Weightman, A., Whitehead, S., Morgan, H., Carter, B., Byrne, E., Turley, R., & Cleves, A. (2012). Tobacco: harm-reduction approaches to smokingShort title: Tobacco: harm reduction.Review 2: The effectiveness of tobacco harm reduction approaches with the intention of quitting(i.e. ‘cutting down to quit’ or ‘reduction to stop smoking’), with and without assistance.
188. Mullen, C., Whalley, B. J., Schifano, F., & Baker, J. S. (2020). Anabolic androgenic steroid abuse in the United Kingdom: An update. British Journal of Pharmacology. https://doi.org/10.1111/bph.14995
189. Murray, T. H. (2020). The Coercive Power of Drugs in Sports. Routledge eBooks. https://doi.org/10.4324/9781003075004-4
190. Murty, O. (2008). Plastic bag asphyxia with LPG (butane-propane) inhalation -Fatal Asphyxiphilia or Suicide?. Journal of Indian Academy of Forensic Medicine. https://doi.org/10.1177/0971097320080409
191. Nabben, T., & Korf, D. J. (2016). Drugs in rurale gebieden: GHB-gebruik en -handel op het Nederlandse platteland. Tijdschrift over Cultuur & Criminaliteit. https://doi.org/10.5553/tcc/221195072016006002005
192. Nainggolan, M., Zahara, E., & Saparuddin, S. (2010). PERANAN HAKIM DALAM MEMBERIKAN PERLINDUNGAN HUKUM TERHADAP ANAK KORBAN PENYALAHGUNAAN NARKOTIKA (STUDI PENGADILAN NEGERI LUBUK PAKAM). DOAJ (DOAJ: Directory of Open Access Journals).
193. Nascimento, M. V. S. D., Barbosa, M. R., Gomes, L. P. D. S., & Fonseca, B. L. (2016). MESA REDONDA : RECURSOS ERGOGÊNICOS E DOPING. DOPING NO ESPORTE. Caderno de Graduação - Ciências Biológicas e da Saúde - UNIT - SERGIPE.
194. Newman, R. K., Dijkstra, B. L., & Gibson, J. (2019). Disk Battery Ingestion. StatPearls.
195. NICHOLS, M. H., Wason, S., REY, J. G. D., & BENFIELD, M. (1995). Baking soda. Pediatric Emergency Care. https://doi.org/10.1097/00006565-199504000-00014
196. Nieva, G. (2015). Tractament del tabaquisme: psicopatologia i personalitat. TDX (Tesis Doctorals en Xarxa).
197. Norell, S. E. (1995). Answers to Exercises. https://doi.org/10.1093/oso/9780195074901.003.0009
198. Novotny, T. E., Hardin, S. R., Hovda, L. R., Novotny, D. J., McLean, M. K., & Khan, S. A. (2011). Tobacco and cigarette butt consumption in humans and animals. Tobacco Control. https://doi.org/10.1136/tc.2011.043489
199. Np, J., Bo, S., & Eames, M. (1990). Baby bottles and family rattles. Children and substance abuse.. PubMed.
200. O'Flynn, R. R. (1988). Do organic solvents ‘cause’ dementia?. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.930030103
201. ODEN, M. S. (2015). If Drug Abuse Is the Answer, Then What Is the Question?. Routledge eBooks. https://doi.org/10.1201/b19237-14
202. Oliveira, G. A. C. D., Pinho, G. C., Jesus, M. C. D., Souza, R. B. D., Bifano, S. S., Marcondes, T. R., Silva, Y. C. D., & Zanetta, S. F. R. (2020). USO DE DROGAS POR ESTUDANTES DE MEDICINA DO CENTRO UNIVERSITÁRIO SÃO CAMILO. Blucher Medical Proceedings. https://doi.org/10.5151/comsuc2019-02
203. Oliver, R. E. W. (1970). Liaison Officers for Hospital Junior Doctors. BMJ. https://doi.org/10.1136/bmj.1.5696.632-b
204. Olzhabayeva, Z., & Saparov, K. (2020). MORPHOLOGICAL AND BIOCHEMICAL STUDY OF THE BLOOD COMPOSITION AFTER PROLONGED EXPOSURE TO TOBACCO SMOKE IN WHITE RATS. SERIES OF BIOLOGICAL AND MEDICAL. https://doi.org/10.32014/2020.2519-1629.18
205. Osinubi, O., & Slade, J. (2001). Tobacco in the workplace.. PubMed.
206. Ostap‐Chęć, M., Opalek, M., Stec, D., & Miler, K. (2021). The study dataset from Discontinued alcohol consumption elicits withdrawal symptoms in honeybees. Figshare. https://doi.org/10.6084/m9.figshare.14716654
207. Pangtey, A., Tiwari, R. C., Dikshit, M., Sharma, V. B., & Mittal, B. (2024). THE PERSISTENT GRIP OF CHEWING TOBACCO AND ITS HARMFUL EF-FECTS ON AN INDIVIDUAL – A REVIEW ARTICLE. International Ayurvedic Medical Journal. https://doi.org/10.46607/iamj2312112024
208. Pardo, G., & Pilar, M. (2015). Influences of social stress in the rewarding effects of mdma and alcohol.
209. Parente, G. G. (2014). MULHER DEPENDENTE QUIMICA EM TRATAMENTO EM SERVIÇO ESPECILIZADO: CASO CLINÍCO. 11º Congresso Internacional da Rede Unida.
210. Parry-Jones, B. (1992). Pagophagia, or compulsive ice consumption: a historical perspective. Psychological Medicine. https://doi.org/10.1017/s0033291700038022
211. Pashchenko, D. A., & Kornyakova, V. V. (2024). The impact of smoking e-cigarettes on human health. Scientific Bulletin of the Omsk State Medical University. https://doi.org/10.61634/2782-3024-2024-14-71-76
212. Pastor, F. P. (2002). Imagen social de las bebidas alcohólicas. Adicciones. https://doi.org/10.20882/adicciones.521
213. Pavić, I., Vlahović, I. G., Pavić, I., & Čurlin, M. (2015). Pasivno pušenje i poremećaji dišnog sustava u djece. Paediatria Croatica. https://doi.org/10.13112/pc.589
214. Peoples, R. W. (2002). Alcohol Actions on Glutamate Receptors. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_23
215. Perry, M., Buerke, M., Szücs, A., Allen, T. A., Bruin, W. B. D., Szántó, K., & Dombrovski, A. Y. (2021). A lifetime of challenges: Real-life decision outcomes in early- and late-onset suicide attempters. Journal of Affective Disorders Reports. https://doi.org/10.1016/j.jadr.2021.100105
216. Petekkaya, S., Ayaz, N., Doğan, M., Oruç, M., Öner, B. S., Göktürk, C., Çelebi, A., Budak, A., Soylu, Ö., & Çelbiş, O. (2016). A Case of Sudden Death due to Lighter Refill Gas Inhalation / Cakmak Gazi Inhalasyonuna Bagli Ani Gelisen Olum Olgusu. Journal of Turgut Ozal Medical Center. https://doi.org/10.5455/jtomc.2015.2885
217. Phoon, W. O. (1989). Poisoning Among Children. Asia Pacific Journal of Public Health. https://doi.org/10.1177/101053958900300401
218. Piotrowicz, K., Piotrowicz, H., Kurzeja, J., Bajkacz, A., Kraśnik, W., Jankowska, O., Rogala, A., & Osmólska, J. (2025). Longevity Recipe - Lifestyle Influences on the Quantity and Quality of Life. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2025.77.56972
219. Plawecki, M. H., White, K., Kosobud, A., Grahame, N. J., Zimmermann, U., Crabb, D. W., & O’Connor, S. (2018). Sex Differences in Motivation to Self‐Administer Alcohol After 2 Weeks of Abstinence in Young‐Adult Heavy Drinkers. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.13860
220. Pomerleau, C. S., Berman, B., Gritz, E. R., Marks, J. L., & Goeters, S. (1994). Why Women Smoke. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-0299-8_2
221. Pontón, M. P. P., Ruilova, J. D. C., Laborda, M. J. M., & Álvarez, L. E. G. (2019). Efectos de la vitamina D en prevención del asma. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(2).abril.2019.781-810
222. Powell, M. (1990). Reducing the costs of alcohol in the workplace: the case for employer policies. RePEc: Research Papers in Economics.
223. Praveen, S., Chandra, Y. G., & Setty, S. (2009). Death Due to Solvent Abuse – A Case Report. Journal of Forensic Medicine.
224. Prayoga, H. D., & Asri, N. (2019). PENYALAHGUNAAN AMPHETAMIN PADA ATLET TINJU. Riyadhoh Jurnal Pendidikan Olahraga. https://doi.org/10.31602/rjpo.v1i1.1723
225. Press, E., & Done, A. K. (1967). SOLVENT SNIFFING. PEDIATRICS. https://doi.org/10.1542/peds.39.4.611
226. Prokopchuk, O., Neumann, P., Hüser, N., Friess, H., & Wilhelm, D. (2019). Multiple intestinal intussusceptions caused by highly impaired gastrointestinal motility in a patient with chronic cannabis consumption. Journal of Surgical Case Reports. https://doi.org/10.1093/jscr/rjz160
227. Puchner, S. (2010). Einfluss der Nikotinabhängigkeit auf den Lebensstil und das damit verbundene Gesundheitsverhalten.
228. Puente, E. O. V., Ángel-García, J. E. D., Méndez, A. P. C., Cisneros, M. A. L., González, S. C. E., & Mata, J. L. V. (2025). Reflexología Facial para Reducir el Estrés y Consumo de Alcohol en Adultos Mexicanos. Revista Veritas de Difusão Cientifica.. https://doi.org/10.61616/rvdc.v6i2.810
229. Pytell, J. D., & Rastegar, D. A. (2020). Cannabinoids. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0010
230. Quittschalle, J., Pabst, A., Löbner, M., Heser, K., Wagner, W., Hajak, A., König, H., Luppa, M., & Riedel‐Heller, S. G. (2021). Wie wirken sich Alkohol- und Tabakkonsum auf die Entwicklung einer Depression im Alter aus? Ergebnisse einer quantitativen Untersuchung hochaltriger Frauen und Männer. Das Gesundheitswesen. https://doi.org/10.1055/s-0041-1732016
231. Racette, S., & Sauvageau, A. (2008). Suicide in the Bath Using Weight and Elevation of Feet. American Journal of Forensic Medicine & Pathology. https://doi.org/10.1097/paf.0b013e318165c0ec
232. Ramaiah, V. V., Ss, M. A. R., Alfawzan, A. A., Mulla, M., Babaji, P., & Hr, L. S. (2020). Oral manifestations and oral health care among the illicit drug abusers: A review. Journal of Critical Reviews.
233. Rastegar, D. A. (2020). Inhalants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0011
234. Rastegar, D. A. (2025). Inhalants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197796207.003.0011
235. Rattan, S. I. S. (2015). Nutrition and food for health and longevity. International journal of Nutrition Pharmacology Neurological Diseases. https://doi.org/10.4103/2231-0738.153789
236. Rawson, R. A., Huber, A., Brethen, P., Obert, J. L., & Gulati, V. (2002). Consumidores de cocaína y metanfetamina: diferencias, características y retención en tratamiento. RET: revista de toxicomanías.
237. Ray, A., & Mohapatra, D. (2019). Life Threatening Effects of Oral Habits. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2019.03647.7
238. Rebec, G. V. (2005). Addiction. Encyclopedia of Cognitive Science. https://doi.org/10.1002/0470018860.s00649
239. Ribeiro, M. A., Júnior, E. E. D. M., Brito, C. R. D. S., Paixão, A. G. D., Costa, D. G. M. D., Alves, V. L. D. S., Freitas, D. G. D., Costa, M. A. R. D., Filho, I. J. D. S., & Oliveira, R. F. D. (2024). Impacts of caffeine consumption in the workplace: from moderate use to dependence. Concilium. https://doi.org/10.53660/clm-3670-2409
240. riswandi, B. (2019). Banyaknya penyalahgunaan narkoba di Indonesia. https://doi.org/10.31227/osf.io/589rc
241. Roberts, J. K., Chow, J. S. F., & Trivedi, K. (2021). Adult-Onset Asthma Associated With E-Cigarette Use. Cureus. https://doi.org/10.7759/cureus.19190
242. Robson, P. (2009). Ecstasy and other ‘party drugs’. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199559961.003.0009
243. Rocha, J. T. D. C., Torezani, J. P., Cocheto, J. G. G., & Caetano, L. S. (2019). O DESCARTE DOMICILIAR DE MEDICAMENTOS PELA POPULAÇÃO DE COLATINA/ES. Unesc em Revista. https://doi.org/10.54578/unesc.v2i2.67
244. Rocha, M. I. D. U. M. D., Lera, J. P. B., Jardim, G. B. G., Mucellini, A. B., Cirolini, L., Jung, I. E. D. C., Mânica-Cattani, M. F., Silveira, A. F. D., Filho, O. C. D. S., & Cruz, I. B. M. D. (2010). Lifestyle, health characteristics and alcohol abuse in young adults who are non-daily smokers. Sao Paulo Medical Journal. https://doi.org/10.1590/s1516-31802010000600008
245. Rodak, K., Kokot, I., & Kratz, E. M. (2021). Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe?. Nutrients. https://doi.org/10.3390/nu13093088
246. Rodríguez‐Arias, M., Navarrete, F., Arenas, M. C., Aguilar, M., Rubio, G., Miñarro, J., & Manzanares, J. (2015). SY29-3SOCIAL DEFEAT IN ADOLESCENT MICE INCREASES VULNERABILITY TO ALCOHOL CONSUMPTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agv076.120
247. Rogers, T., Milkman, K. L., & Volpp, K. G. (2014). Commitment Devices. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000455018.85064.22
248. Roopchandani, K., Singhvi, I., & Kar, M. (2008). Smoking cessation aids. Asian Journal of Pharmaceutics. https://doi.org/10.22377/ajp.v2i4.205
249. Rose, G. S., & Walters, S. T. (2012). Theories of Motivation and Addictive Behavior.
250. Rovesti, S., Vivoli, R., & Bergomi, M. (2012). Stress indotto dalla guida di autoveicoli: studio di parametri psicofisiologici. Italian Journal of Public Health. https://doi.org/10.2427/6250
251. Roy, B. A. (2019). Eight (Plus Two) Musings from Reading This Issue. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000495
252. Safdar, G. (2016). Impacts of Drugs Addiction on Users: Medical and Psychological Perspectives. New media and mass communication. https://doi.org/10.7176/nmmc.vol5357-62
253. Sahu, S., Nagarajappa, R., Sahoo, K., Naik, D., Sahu, N., Kiran, K., & Tutor, S. (2020). Vaping: Realities in its Effect on Oral Health. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v14i4.13079
254. Saker, P., Farrell, M. J., Egan, G. F., McKinley, M. J., & Denton, D. A. (2016). Overdrinking, swallowing inhibition, and regional brain responses prior to swallowing. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1613929113
255. Samartino, S. D. L., Pereira, I. V., Leal, G. D. N., Mendonça, G. J. G. D., Silva, M. H., Margato, M. M., Freitas, I. S. D., Ferreira, A. M., Ferraz, G. C., Neto, J. S. D. S., Samartino, M., ALFAIA, A. D., Telles, J. M., Medeiros, E. L. D. A., & Ferraz, L. P. D. C. (2024). Uso do cigarro eletrônico e seu impacto no sistema respiratório. Caderno Pedagógico. https://doi.org/10.54033/cadpedv21n7-142
256. Santovecchi, P., & Giannoni, S. (2012). Energy Drink e Alcool: un cocktail pericoloso.
257. Sasano, T., Satoh‐Kuriwada, S., Shoji, N., Sekine-Hayakawa, Y., Kawai, M., & Uneyama, H. (2010). Application of Umami Taste Stimulation to Remedy Hypogeusia Based on Reflex Salivation. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.33.1791
258. Schlabach, G. (1994). Carbohydrate strategies for injury prevention.. Journal of Athletic Training.
259. Schlagintweit, H. E., & Barrett, S. P. (2016). Does acute tobacco smoking prevent cue-induced craving?. Journal of Psychopharmacology. https://doi.org/10.1177/0269881116639288
260. Schneble, H. (1995). UNREDLICHE WERBUNG? - PROMILLEKILLER UND ALCOTESTER. Blutalkohol.
261. Schwenk, T. L. (1997). Psychoactive Drugs and Athletic Performance. The Physician and Sportsmedicine. https://doi.org/10.3810/psm.1997.01.1088
262. Sharma, M., bairwa, J. P., & Goyal, S. (2025). Role of Ayurveda in the Management of Alcohol Addiction: A Case Report. International Research Journal of Ayurveda & Yoga. https://doi.org/10.48165/irjay.2025.80505
263. Shirley, T. (2020). Treatment Compliance for Drug addiction. Journal of Clinical Toxicology.
264. Simlai, J., & Khess, C. R. J. (2008). Inhalant abuse in the youth : A reason for concern. DOAJ (DOAJ: Directory of Open Access Journals).
265. Singh, L., Joshi, T., Tewari, D., Echeverría, J., Mocan, A., Sah, A. N., Parvanov, E. D., Tzvetkov, N., Feei, Z., Lee, Y. Y., Poznański, P., Huminiecki, Ł., Sacharczuk, M., Jóźwik, A., Horbańczuk, J. O., Feder‐Kubis, J., & Atanasov, A. G. (2020). Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01593
266. Slater, G., Rice, A., Jenkins, D., & Hahn, A. G. (2014). Body mass management of lightweight rowers: nutritional strategies and performance implications. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2014-093918
267. Smith, D. E., & Seymour, R. B. (1998). CANNABIS ADDICTION AND WITHDRAWAL: ATTITUDES AND IMPLICATIONS. CRC Press eBooks. https://doi.org/10.1201/9780203304228-17
268. Smith, K. E., Archuleta, A. J., Staton, M., & Winston, E. (2020). Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2020.1725032
269. Smith, V. C., & Jones, K. L. (2021). What a birth mother wants paediatricians to know about diagnosing a fetal alcohol spectrum disorder. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2021-322333
270. Sousa, J., Sousa, J. L. B. D., Martins, J., Titato, L. D. R., Martins, M., Prado, C. M., Armelin, R. B. S., & Lima, J. F. D. (2025). IMPACTOS DO CIGARRO ELETRÔNICO NA SAÚDE DOS JOVENS: ESTRATÉGIAS DE ENFERMAGEM PARA PREVENÇÃO. Editora Científica Digital eBooks. https://doi.org/10.37885/250619447
271. Sp, G. (1980). Long-term adverse effects of brief marijuana usage.. PubMed.
272. Stanley, A. K., & Ward, M. N. (1994). 5. Anabolic Steroids — The Drugs That Give and Take Away Manhood. A Case with an Unusual Physical Sign. Medicine Science and the Law. https://doi.org/10.1177/002580249403400115
273. Stein, R. J., Pyle, S. A., Haddock, C. K., Poston, W. S. C., Bray, R. M., & Williams, J. (2008). Reported Stress and Its Relationship to Tobacco Use among U.S. Military Personnel. Military Medicine. https://doi.org/10.7205/milmed.173.3.271
274. Stern, T. A., Gross, A. F., Stern, T. W., Nejad, S. H., & Maldonado, J. R. (2010). Current Approaches to the Recognition and Treatment of Alcohol Withdrawal and Delirium Tremens: “Old Wine in New Bottles” or “New Wine in Old Bottles”. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.10r00991ecr
275. Stone, M. H. (2015). Marijuana and Psychosis: The Effects of Adolescent Abuse of Marijuana and other Drugs in a Group of Forensic Psychiatric Patients. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000188
276. Straussner, S. L. A., Straussner, S. B., & Einstein, S. (2012). Alcohol Use Disorder. Social Work. https://doi.org/10.1093/obo/9780195389678-0025
277. Sánchez, J. D. A., Fonayet, F. V., Sánchez-Aragón, A., Pastor, I., & Eraso, Á. G. B. (2024). Explanatory factors of polydrug use in mid-late teens and the relevance of information sources: Correlational and configurational assessment in Tarragona (Spain). AIMS Public Health. https://doi.org/10.3934/publichealth.2024039
278. Talwar, D., Sunil, K., Acharya, S., Jagtap, G. S., & Hepat, S. (2021). A Curious Case of Snake Venom Addiction as an Alcohol De-Addiction Tool: Pain for Gain?. Cureus. https://doi.org/10.7759/cureus.19996
279. Tania, T., Campos-Ordonez, Oscar, O., & Gonzalez-Perez (2016). Glial plasticity after hexahydrobenzene exposure. 中国神经再生研究：英文版.
280. Te, K. (1997). Management of dental staining: can low-abrasive dentifrices play a role?. PubMed.
281. Teixeira, M. G. D. S., & Júnior, R. D. A. V. (2024). IMPACTO DA UTILIZAÇÃO DE CIGARROS ELETRÔNICOS NA SAÚDE BUCAL. Revista Foco. https://doi.org/10.54751/revistafoco.v17n9-144
282. Tenenbein, M. (1997). Leaded gasoline abuse: the role of tetraethyl lead. Human & Experimental Toxicology. https://doi.org/10.1177/096032719701600411
283. Thamotharan, S., & Conrad, S. M. (2015). Gender‐responsive considerations for substance‐using adolescent girls. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30085
284. Thompson, J. P. (2009). Toxicology of Substances that Affect Performance and Behaviour. General, Applied and Systems Toxicology. https://doi.org/10.1002/9780470744307.gat147
285. Thuring, J. W. G. M., & Schönbaum, E. (1994). Hypothermia and Social Behaviour in Mice. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7429-8_71
286. Tiwari, K. (2020). Supplement (mis)use in adolescents. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0000000000000912
287. Tonstad, S., & Els, C. (2010). Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity. Clinical Medicine Insights Therapeutics. https://doi.org/10.4137/cmt.s4012
288. Towner, T. T., & Varlinskaya, E. I. (2020). Adolescent Ethanol Exposure: Anxiety-Like Behavioral Alterations, Ethanol Intake, and Sensitivity. Frontiers in Behavioral Neuroscience. https://doi.org/10.3389/fnbeh.2020.00045
289. Tuñas, M. F., Bonete, R. P., & Pérez‐Muñuzuri, A. (2008). Drogadicción en el embarazo: un problema emergente. Metas de Enfermería.
290. Unknown (2002). Les substances inhalées. Paediatrics & Child Health. https://doi.org/10.1093/pch/7.2.107
291. Vaibhavi, P. S., & Shivakumar, B. K. (2024). Inhalant Abuse in a Teenager with Depression: A Case Report. Journal of Medical Sciences and Health. https://doi.org/10.46347/jmsh.v10.i2.23.12
292. Vanderschuren, L. J. M. J., & Everitt, B. J. (2004). Drug Seeking Becomes Compulsive After Prolonged Cocaine Self-Administration. Science. https://doi.org/10.1126/science.1098975
293. Vicente, J., Flores, G., Talvinder, S., & Moreno, A. R. (2012). Addictive Drugs and Synaptic Plasticity. InTech eBooks. https://doi.org/10.5772/33299
294. Vichyanond, P., Visitsuntorn, N., & Tuchinda, M. (1990). Wheat-induced anaphylaxis.. PubMed.
295. Vinberg, S. (2010). Att förstå cannabisrökning - Fem personer berättar om varför de använder cannabis.
296. Virós, M. C., & López, A. S. (2015). Adicción al ejercicio físico. Tándem: Didáctica de la educación física.
297. Volkova, Y. V., Savoskin, D., & Sydorenko, N. (2019). Energy drinks as a risk factor for students’ health. One Health and Nutrition Problems of Ukraine. https://doi.org/10.33273/2663-9726-2018-49-2-23-27
298. Vyas, N., Sonal, M., Rajesh, V., & Suhaj, A. (2012). Inhalant abuse- A rising public health problem. International Journal of Medical Science and Public Health. https://doi.org/10.5455/ijmsph.2013.2.146-152
299. Vázquez, R. T., & Montoya, V. H. (2004). Riesgos a la salud por presencia del aluminio en el agua potable. Conciencia Tecnológica.
300. Waddell, J. T., Sher, K. J., & Piasecki, T. M. (2021). Coping motives and negative affect: An ecological study of the antecedents of alcohol craving and alcohol use.. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000696
301. Wadikar, D. D., & Premavalli, K. S. (2012). Appetite Control and Obesity. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2010.514757
302. Walker, N., Bullen, C., & McRobbie, H. (2009). Reduced–nicotine content cigarettes: Is there potential to aid smoking cessation?. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntp147
303. Wang, G. S., & Hoyte, C. (2018). Common Substances of Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.2017-0267
304. Wansink, B., & Ittersum, K. V. (2010). Clinical Observation: Spoons Systematically Bias Dosing of Liquid Medicine. SSRN Electronic Journal.
305. Wardani, L. K., Sektiany, A., Matkusa, A. B., Lestari, A. B., Widiana, D., Nanda, E. L., Lusita, E., Kusuma, I. A., Ni’mah, K., Wijayanti, L. A., Gadung, L. B. R. B. L., Decky, L., Rahmawati, M. D., Asadulloh, M. A., Saudale, J. H., & Takubak, M. A. D. (2019). Pendidikan Kesehatan Bahaya Narkoba bagi Kesehatan Mental pada Siswa SMK Al Huda Kota Kediri. https://doi.org/10.30994/jceh.v2i2.15
306. Warner, E. A. K. (1995). Is your patient using cocaine? Clinical signs that should raise suspicion.. PubMed.
307. We, G., & Kersten, H. B. (1980). Prevention of alcohol withdrawal symptoms in surgical patients.. PubMed.
308. Welsh, J. W., Rodriguez, C. P., & Suzuki, J. (2016). Bilateral Upper Extremity Cellulitis From Injecting Crack Cocaine Dissolved in Lemon Juice. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.16l01933
309. Wheeler, M. G., Duncan, E., & Davis, M. (2016). Low startle magnitude may be a behavioral marker of vulnerability to cocaine addiction. Synapse. https://doi.org/10.1002/syn.21943
310. Williams, A. R. (2020). Cannabis as a Gateway Drug for Opioid Use Disorder. The Journal of Law Medicine & Ethics. https://doi.org/10.1177/1073110520935338
311. Williams, K. (2021). Short note on Hangover and its Effects. Journal of Alcoholism and Drug Dependence.
312. Wilson, C. A., Finch, E., Kerr, C. E., & Shakespeare, J. (2020). Alcohol, smoking, and other substance use in the perinatal period. BMJ. https://doi.org/10.1136/bmj.m1627
313. Wilson, K. B. (2020). Obesity: Lifestyle Modification and Behavior Interventions.. PubMed.
314. Winslow, B. T., Onysko, M., & Hébert, M. (2016). Medications for Alcohol Use Disorder.. PubMed.
315. Wood, C. A. (2009). Death And Blindness From Methyl- Or Wood-Alcohol Poisoning: With Means Of Prevention.
316. Woods-Lee, M. C. (2020). Glossary of terms. British Small Animal Veterinary Association eBooks. https://doi.org/10.22233/9781910443828.app1
317. Woody, G. (1970). Visual Disturbances Experienced by Hallucinogenic Drug Abusers While Driving. American Journal of Psychiatry. https://doi.org/10.1176/ajp.127.5.683
318. Wp, J., Pelt, V., Pamj, E., Mc, G., Aw, G., ACde, G., Rh, K., Knapen, V., Krijgsman, M., & Ne, V. B. (2011). GGD-richtlijn medische milieukunde : Kwik in het binnenmilieu en gezondheid.
319. Yadav, S., & Rawal, G. (2015). Counterfeit drugs: problem of developing and developed countries. International Journal of Pharmaceutical Chemistry.
320. Yang, J. C. (2009). Drugs in College. Berkeley Scientific Journal. https://doi.org/10.5070/bs3122007603
321. Yoshioka, T. (2016). [Recovery from Sexual Addiction].. PubMed. https://doi.org/10.11477/mf.1416200572
322. Young, S., Henderson, C. A., & Couperus, K. (2020). The Effects of Electronic Nicotine Delivery Systems on Athletes. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000705
323. Özyürek, D., Çolaklar, M., Canik, B., Kocakır, E., Seyhan, E., Gürlek, E., Yaşar, F., Demircioğlu, İ. G., Kahya, H. H., Orhan, İ. G., Çakmak, M., Uğurlu, N. M., Koyuncu, Ş. N., Bozan, Ş. M., Altın, Y. F., Çotur, Z., Yardim, M. S., & Özcebe, H. (2019). BİR TIP FAKÜLTESİ İNTERN DOKTORLARININ SİGARA İÇME DAVRANIŞLARI VE İLİŞKİLİ FAKTÖRLER. 3.International 21.National Public Health Congress.